Security key
02043Q107
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 130,175,523
- Total 13F shares
- 561,669
- Share change
- 0
- Total reported value
- $173,230,438
- Price per share
- $330.87
- Number of holders
- 23
Report period
Q1 2026
Institutions
23
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of 02043Q107 - Alnylam Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
10%
from 13D/G
|
13,553,932
|
$5,389,721,059 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.5%
|
3,228,956
|
$1,283,994,353 | — | 31 Dec 2025 | |
| Bridgewater Associates, LP |
13F
|
Company |
0.07%
|
85,617
|
$34,045,600 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
38,459
|
$15,293,222 | — | 31 Dec 2025 |
Institutional Holders of Alnylam Pharmaceuticals Inc - Common Stock as of Q1 2026
As of 31 Mar 2026,
Alnylam Pharmaceuticals Inc - Common Stock was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
561,669 shares.
The largest 10 holders included
ROYAL LONDON ASSET MANAGEMENT LTD, ENVESTNET ASSET MANAGEMENT INC, Mirae Asset Global Investments Co., Ltd., ARIZONA STATE RETIREMENT SYSTEM, Thrivent Financial for Lutherans, HANTZ FINANCIAL SERVICES, INC., MML INVESTORS SERVICES, LLC, FIFTH THIRD BANCORP, PRINCIPAL FINANCIAL GROUP INC, and J. Safra Sarasin Holding AG.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
4
Q1 2026 holders
23
Holder diff
19
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.